The multidisciplinary treatment of rectal cancer: Pathology

Annals of Oncology

Volumn 18, Issue SUPPL. 9, 2007, Pages

  Nagtegaal, I D ^a   van Krieken, J H J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; INTERDISCIPLINARY COMMUNICATION; LAPAROSCOPIC SURGERY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM BIOPSY; RECTUM CANCER; RECTUM CARCINOMA; RECTUM SURGERY; TREATMENT INDICATION; TREATMENT RESPONSE; TUMOR REGRESSION; ADJUVANT THERAPY; CLASSIFICATION; DRUG THERAPY; LYMPH NODE METASTASIS; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RECTUM TUMOR; REVIEW; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE; VASCULARIZATION;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DRUG THERAPY; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36048973252     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm306     Document Type: Conference Paper

References (25)

1. Lee W, Lee D, Choi S et al. Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 2003; 17: 1283-1287.
2. Bentrem DJ, Okabe S, Wong WD et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 2005; 242: 472-477.
3. Borschitz T, Heintz A, Junginger T. The influence of histopathologic criteria on the long-term prognosis of locally excised pT1 rectal carcinomas: Results of local excision (transanal endoscopic microsurgery) and immediate reoperation. Dis Colon Rectum 2006; 49: 1492-1506.
4. Wang HS, Liang WY, Lin TC et al. Curative resection of T1 colorectal carcinoma: Risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 2005; 48: 1182-1192.
5. Nascimbeni R, Burgart LJ, Nivatvongs S et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45: 200-206.
6. Yamamoto S, Watanabe M, Hasegawa H et al. The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology 2004; 51: 998-1000.
7. Okabe S, Shia J, Nash G et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 2004; 8: 1032-1039.
8. Tominaga K, Nakanishi Y, Nimura S et al. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005; 48: 92-100.
9. Oh-e H, Tanaka S, Kitadai Y et al. Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer. Dis Colon Rectum 2001; 44: 1129-1136.
10. Masaki T, Muto T. Predictive value of histology at the invasivemargin in the prognosis of early invasive colorectal carcinoma. J Gastroenterol 2000; 35: 195-200.
11. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002; 45: 628-634.
12. Goldstein NS, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens - Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 1999; 111: 51-58.
13. Nagtegaal ID, van de Velde CJH. van der Worp E et al. Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-1734.
14. Nagtegaal ID, van de Velde CJH, Marijnen CAM et al. Low rectal cancer; a pathologists' call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-9264.
15. Quirke P, Sebag-Montefiore D, Steele R et al. Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by preoperative short course radiotherapy. Preliminary results of the MRC CR07 trial. J Clin Oncol 2006; 24: A3512.
16. Marijnen CAM, Nagtegaal ID, Klein Kranenbarg E et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976-1984.
17. Gosens MJEM, Van Krieken JH, Rutten H et al. A critical appraisal of therapy induced tumor regression in rectal carcinoma. Ann Oncol 2006; 17(suppl.1): I31 (PO-62).
18. Read TE, McNevin MS, Gross EK et al. Neoadjuvant therapy for adenocarcinoma of the rectum: Tumor response and acute toxicity. Dis Colon Rectum 2001; 44: 513-522.
19. Vecchio FM, Valentini V, Minsky BD et al. The relationship of pathologic tumor regression grade (TGR) and outcomes after preoperative therapy in rectal cancer. Int. J. Rad.Oncol. Biol. Phys. 2005; 62: 752-760.
20. Gavioli M, Luppi G, Losi L et al. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis. Colon Rectum 2005; 48: 1851-1857.
21. Rodel C, Martus P, Papadoupolos T. Prognostic significance of tumour regression after preoperative chemoradiation for rectal cancer. J Clin Oncol 2006; 23: 8688-8696.
22. Bouzourene H, Bosman FT, Seelentag W et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 94: 1121-1130.
23. Maslekar S, Sharma A, Macdonald A et al. Mesorectal Grades Predict Recurrences After Curative Resection for Rectal Cancer. Dis Colon Rectum 2007; 50(2): 168-175.
24. Breukink SO, Grond AJ, Pierie JP et al. Laparoscopic vs open total mesorectal excision for rectal cancer: An evaluation of the mesorectum's macroscopic quality. Surg Endosc 2005; 19: 307-310.
25. Benson AB, Schrag D, Somerfield MR et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 3408-3419.